Skip to content

Clinical trials

Pulmonary Embolism trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Country / region: Norway Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20061
20075
20091
20101
20111
20132
20141
20171
20181
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated2
Active, not recruiting1
Recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Bristol-Myers Squibb3
Sanofi3
Anthos Therapeutics, Inc.2
Daiichi Sankyo2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Helsinki University Central Hospital1
Oslo University Hospital1
Ostfold Hospital Trust1
SECRETO Study Consortium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism20
Venous Thrombosis15
Venous Thromboembolism6
Thrombosis4
Thromboembolism2
Atrial Fibrillation1
Brain Infarction1
Dyspnea1
Embolism1
Foramen Ovale, Patent1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.